Lannett Receives FDA Approval for Generic Brethine

The FDA has approved Lannett's abbreviated new drug application for terbutaline sulfate tablets in 2.5- and 5-mg dosage strengths.

Terbutaline sulfate is the generic version of Novartis Pharmaceuticals' Brethine tablets. The product is indicated for the prevention and reversal of bronchospasm, or sudden constriction of the airways, in patients 12 years and older with asthma or reversible bronchospasm associated with bronchitis and emphysema.